EFFECT OF VARIOUS SUSTAINED RELEASE POLYMERS ON FLOATING TABLETS OF CARVEDILOL PHOSPHATE-A COMPARATIVE STUDY
DOI:
https://doi.org/10.22159/ijap.2023v15i6.49170Keywords:
Carvedilol phosphate, Floating, Polymers, Sustained releaseAbstract
Objective: This study aimed to develop floating tablets of Carvedilol phosphate containing various excipients such as HPMC K100M, Carbopol, Polyox WSR, HPMC K4M, and sodium bicarbonate to generate gas. Additionally, the impact of DCP, spray dried lactose, and HPβCD on drug release was investigated.
Methods: A total of eighteen formulations were prepared using the direct compression method and evaluated for hardness, drug content, friability, floating lag time, floatation time and drug release properties.
Results: FTIR analysis confirmed that there were no chemical interactions between Carvedilol phosphate and the excipients used in the formulation of the floating tablets. Most of the Carvedilol phosphate floating tablets, except for F9 and F10, did not disintegrate in water, alkaline fluids (pH 7.4), or acidic aqueous solutions (pH 1.2). These tablets exhibited satisfactory quality attributes in terms of hardness, drug content, and friability, making them suitable for sustained release. The floating lag time of the tablets ranged from 25 seconds to 34 min, while the floating duration varied from 2 to 24 h. The drug release from the tablets was gradual and sustained over 12 h, depending on the composition of the tablets. Polyox WSR (F9 and F10) resulted in a rapid drug release, whereas an increase in the polymer concentration led to a decrease in the rate of drug release across all formulations.
Conclusion: The study reveals that the use of hydrophilic polymers enhanced the drug release, whereas hydrophobic polymers decreased the drug release. As such, formulations, F11, F15, and F16, which gave 100% drug release within 12 h are finalized as the optimized formulations of Carvedilol phosphate floating tablet.
Downloads
References
https://en.org/wiki/carvedilol.wikipedia. [Last accessed on 13 Oct 2023]
https://go.drugbank.com/drugs/DB01136. [Last accessed on 13 Oct 2023]
Mohapatra PK, Satyavani CH, Sahoo SA. The Design and development of carvedilol gastroretentive floating drug delivery systems using hydrophilic polymers and in vitro characterization. Int J Pharm Pharm Sci. 2020 Jul 1;12(7):66-73. doi: 10.22159/ijpps.2020v12i7.38024.
Qin C, Wu M, Xu S, Wang X, Shi W, Dong Y. Design and optimization of gastro-floating sustained-release tablet of pregabalin: in vitro and in vivo evaluation. Int J Pharm. 2018 Jul 10;545(1-2):37-44. doi: 10.1016/j.ijpharm.2018.04.011, PMID 29649518.
Tran PHL, Tran TTD. Dosage form designs for the controlled drug release of solid dispersions. Int J Pharm. 2020 May 15;581:119274. doi: 10.1016/j.ijpharm.2020.119274, PMID 32234566.
Djuris J, Milovanovic S, Medarevic D, Dobricic V, Dapcevic A, Ibric S. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions. Int J Pharm. 2019 Jan 10;554:190-200. doi: 10.1016/j.ijpharm.2018.11.015, PMID 30414899.
Desai S, Bolton S. A floating controlled-release drug delivery system: in vitro-in vivo evaluation. Pharm Res. 1993 Sep;10(9):1321-5. doi: 10.1023/a:1018921830385, PMID 8234170.
Hilton AK, Deasy PB. In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxycillin trihydrate. International Journal of Pharmaceutics. 1992 Oct 10;86(1):79-88. doi: 10.1016/0378-5173(92)90033-X.
Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: a review. AAPS PharmSciTech. 2005 Sep;6(3):E372-90. doi: 10.1208/pt060347, PMID 16353995.
Namdev A, Jain D. Floating drug delivery systems: an emerging trend for the treatment of peptic ulcer. Curr Drug Deliv. 2019 Dec 1;16(10):874-86. doi: 10.2174/1567201816666191018163519, PMID 31894738.
Kotreka UK, Adeyeye MC. Gastroretentive floating drug-delivery systems: a critical review. Crit Rev Ther Drug Carrier Syst. 2011;28(1):47-99. doi: 10.1615/critrevtherdrugcarriersyst.v28.i1.20, PMID 21395515.
Hofmann AF, Pressman JH, Code CF, Witztum KF. Controlled entry of orally administered drugs: physiological considerations. Drug Dev Ind Pharm. 1983 Jan 1;9(7):1077-109. doi: 10.3109/03639048309046314.
Nagarwal RC, Ridhurkar DN, Pandit JK. In vitro release kinetics and bioavailability of gastroretentive cinnarizine hydrochloride tablet. AAPS PharmSciTech. 2010 Mar;11(1):294-303. doi: 10.1208/s12249-010-9380-5, PMID 20182827.
Sauzet C, Claeys Bruno M, Nicolas M, Kister J, Piccerelle P, Prinderre P. An innovative floating gastro retentive dosage system: formulation and in vitro evaluation. Int J Pharm. 2009 Aug 13;378(1-2):23-9. doi: 10.1016/j.ijpharm.2009.05.027, PMID 19465095.
Taghizadeh Davoudi E, Ibrahim Noordin M, Kadivar A, Kamalidehghan B, Farjam AS, Akbari Javar H. Preparation and characterization of a gastric floating dosage form of capecitabine. BioMed Res Int. 2013;2013:495319. doi: 10.1155/2013/495319, PMID 24288681.
Chavanpatil M, Jain P, Chaudhari S, Shear R, Vavia P. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation. Int J Pharm. 2005 Nov 4;304(1-2):178-84. doi: 10.1016/j.ijpharm.2005.08.009, PMID 16198522.
Srikanth Meka V, Wee Liang VA, Dharmalingham SR, Sheshala R, Gorajana A. Preparation and in vitro characterization of non-effervescent floating drug delivery system of poorly soluble drug, carvedilol phosphate. Acta Pharm. 2014;64(4):485-94. doi: 10.2478/acph-2014-0038, PMID 25531788.
Rajora A, Nagpal K. A critical review on floating tablets as a tool for achieving better gastric retention. Crit Rev Ther Drug Carrier Syst. 2022;39(1):65-103. doi: 10.1615/CritRevTherDrugCarrierSyst.2021038568, PMID 34936318.
Uppala P, Shaik S, Valluru S, Nalluri B. Development of enteric coated sustained release matrix tablets of sertraline hydrochloride. J App Pharm Sci 2015;5(4):58-64. doi: 10.7324/JAPS.2015.50410.
Jeganathan B, Prakya V. Preparation and evaluation of floating extended release matrix tablet using a combination of polymethacrylates and polyethylene oxide polymers. Int J Pharm Pharm Sci. 2014 Jul 19;6(8):584-92.
Chaitanya K, Velmurugan SE. Formulation and evaluation of levodopa effervescent floating tablets. Int J Pharm Pharm Sci. 2015;7:189-93.
Niharika MG, Krishnamoorthy K, Akkala M. Overview on floating drug delivery system. Int J App Pharm. 2018 Oct 4;10(6):65-71. doi: 10.22159/ijap.2018v10i6.28274.
Published
How to Cite
Issue
Section
Copyright (c) 2023 K. RAVI SHANKAR, SHAIK AMINABEE, KNV CHENCHU LAKSHMI, G. RAMANA REDDY, REEHANA SHAIK, VINEETHA TIYAGURA, SHAIK ALMAAS SULTANA, SHAIK BASHA, KANDEPU MOKESH SAI, JALADI BHAGAVAN, CHELLI DINESH KUMAR
This work is licensed under a Creative Commons Attribution 4.0 International License.
